Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-06-11Clinical Trial Update: New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma [Phase 1, Phase 2]
This clinical trial update notes that the Newcastle Disease Virus (NDV) therapy trial for Glioblastoma, Sarcoma, and Neuroblastoma has been …
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Studying Tumor Samples From Young Patients With Neuroblastoma
A completed clinical trial update focusing on tumor samples from young patients with neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma
A completed clinical trial investigates prognostic biomarkers in tumor tissue from young neuroblastoma patients. The study aims to identify …
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors [Phase 1]
Phase 1 trial of temozolomide combined with O6-benzylguanine in children with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors [Phase 1]
Phase 1 study evaluating radiolabeled monoclonal antibody therapy given after radiation in patients with primary brain tumors; the trial sta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood [Phase 2]
Phase 2 trial of imatinib mesylate in relapsed or refractory pediatric solid tumors has been completed.
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors [Phase 2]
Phase 2 trial results for cixutumumab in relapsed or refractory solid tumors across multiple sarcomas and pediatric cancers.
-
FDA approval · 2015-03-10FDA Approved: UNITUXIN — Original Application (United Therapeutics Corporation)
FDA approved Unituxin (dinutuximab) from United Therapeutics via an original application for treating pediatric patients with high-risk neur…
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors [Phase 1]
This dose-escalation Phase 1 trial evaluated the safety and tolerability of combining Sorafenib with Irinotecan in pediatric patients with s…
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma [Phase 2]
Phase 2 trial evaluating biological therapy (sargramostim) and isotretinoin in relapsed or refractory neuroblastoma has completed with resul…
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma [Phase 3]
Phase 3 trial evaluating a combination including Ch14.18, sargramostim, aldesleukin, and isotretinoin after autologous stem cell transplant …
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: iCAT for Recurrent/Refractory/HR Solid Tumors
A completed clinical trial evaluating iCAT for recurrent/refractory/high-risk solid tumors in pediatric patients, including Neuroblastoma, W…
-
CLINICAL_TRIALS withdrawal · 2014-12-11Clinical Trial Update: Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors [NA]
This clinical trial update indicates that Vanderbilt University’s study on early enteral tube feedings for children undergoing chemotherapy …
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma [Phase 1]
Phase 1 pilot study evaluating the combination of zoledronic acid and interleukin-2 in children with refractory neuroblastoma. The trial sta…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Ixabepilone in Treating Young Patients With Refractory Solid Tumors [Phase 2]
Phase 2 trial update on ixabepilone in young patients with refractory solid tumors. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant [NA]
A completed clinical trial evaluated adding aprepitant to granisetron and dexamethasone to prevent nausea and vomiting in patients receiving…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma [Phase 2]
Clinical trial update reports results from a Phase 2 study of thalidomide plus temozolomide in relapsed or progressive pediatric central ner…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [Phase 1]
This document provides a Phase 1 clinical trial update on using Interleukin-12 to treat various hematologic cancers and solid tumors; the st…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer [Phase 2]
Phase 2 trial evaluating a five-drug combination (etoposide, cyclophosphamide, thalidomide, celecoxib, and fenofibrate) in relapsed or progr…
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma [Phase 2]
This Clinical Trial Update reports the completion of a Phase 2 study evaluating 131I-MIBG for treating patients with refractory or relapsed …
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors [Phase 1]
A Phase 1 clinical trial update notes the completion of a biological therapy study in children with refractory or recurrent neuroblastoma or…
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: Combination Chemotherapy in Treating Children With Neuroblastoma [Phase 3]
A Phase 3 clinical trial evaluating combination chemotherapy for treating pediatric neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Vinorelbine in Treating Children With Recurrent or Refractory Cancers [Phase 2]
Phase 2 clinical trial of vinorelbine in children with recurrent or refractory cancers completed; the study evaluated vinorelbine in pediatr…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors [Phase 2]
A Phase 2 trial by the Children's Oncology Group evaluated radiation therapy, chemotherapy, and peripheral stem cell transplantation for pri…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma [Phase 1]
A Phase 1 trial evaluating the safety of combining chemotherapy with peripheral stem cell transplantation followed by surgery and/or radiati…